Previous Close | 435.00 |
Open | 433.51 |
Bid | 415.16 x 100 |
Ask | 433.91 x 100 |
Day's Range | 424.01 - 435.90 |
52 Week Range | 274.98 - 602.59 |
Volume | |
Avg. Volume | 22,914 |
Market Cap | 759.424M |
Beta (5Y Monthly) | 0.61 |
PE Ratio (TTM) | 39.09 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 8.80 (2.03%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | N/A |
ALLEN, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2023 and the full year 2023. For the fourth quarter of 2023 compared to the fourth quarter of 2022, revenues were $43.6 million, up $729 thousand, operating income was $6.7 million, down $2.1 million, and net income was $6.4 million, down $1.9 million. Fourth quarter 2023 diluted earnings per share were $3.65 compared to $4.70 for the fourth quar
ALLEN, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2023. Revenues for the third quarter of 2023 totaled $41.9 million compared to $44.6 million for the same period in 2022. For the quarter ended September 30, 2023, operating income was $4.1 million, down $5.5 million from the comparable 2022 period, and net income was $2.9 million, down $5.9 million from the same period in 2022. Third quarter 202
ALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019, Ms. Bankes served in leadership positions across multiple div